Search results for "Hepatocellular carcinoma"


 
Results 1 - 10 of about 17 for "Hepatocellular carcinoma".

Statins associated with reduced mortality risk in hepatocellular carcinoma | ACP Gastroenterology Monthly

Inverse associations between postdiagnosis statin use and cancer-specific and all-cause mortality were consistent for low- and high-dose statins and for a range of time periods after cancer diagnosis.

Regorafenib now FDA-approved to treat hepatocellular carcinoma | ACP Gastroenterology Monthly

Approved use of the drug has been expanded to include treatment of patients with hepatocellular carcinoma who have been treated with sorafenib.

February 24, 2017 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

Spotlight on cirrhosis | ACP Gastroenterology Monthly

Patients with cirrhosis were the focus of several recent studies, which reviewed the evidence behind nutritional assessment, calculated the cost-effectiveness of hepatocellular carcinoma screening, and estimated the prevalence of nonalcoholic

More liver transplants occurring in patients with alcohol-associated liver disease | ACP Gastroenterology Monthly

The increase from 2002 to 2016 can partly be explained by reductions in hepatitis C-related transplants but may also indicate changing perspectives on abstinence requirements, study authors said.

MKSAP quiz: HCV-related cirrhosis with decompensation | ACP Gastroenterology Monthly

This month's quiz asks readers to determine the next step in management for a 64-year-old man with hepatitis C virus (HCV)-related decompensation.

Spotlight on hepatocellular cancer | ACP Gastroenterology Monthly

One recent study assessed occurrence of hepatocellular carcinoma in patients with hepatitis C-associated cirrhosis, while another looked at the effect of hepatobiliary cancer surveillance on outcomes in patients with primary sclerosing cholangitis.

Daily aspirin may reduce risk of hepatitis-related liver cancer | ACP Gastroenterology Monthly

A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.

ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

January 25, 2019 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   1   2   Next